Charles W. Stark

MedicineEngineeringChemistryBiochemistry, Genetics and Molecular BiologyChemical Engineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial”.

Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial

Cardiovascular Research(2024)10.1093/cvr/cvae057

N/A

1.0DataRank · unranked

30 citations

Michael H. Davidson, Prediman K. Shah, Charles W. Stark, Wenqi Lu, Cheerag Shirodaria +5 more